Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
暂无分享，去创建一个
D. Kuritzkes | R. Leavitt | L. Na | J. Currier | T. Brown | G. McComsey | F. Aweeka | S. Cohn | H. Ribaudo | I. Ofotokun | R. Landovitz | C. Godfrey | M. Para | J. Lennox | M. Sagar | A. Villasis-Keever | K. Patterson | B. Baugh